Pfizer employee to new colleagues: Buckle up
Pfizer employee to new colleagues: Buckle upPharma giant Pfizer got bigger on Monday, purchasing Wyeth Pharamceuticals for $65 billion in one of the few big business moves to get funding lately. This...
View ArticleAngell on drug money: Just say No
Angell on drug money: Just say NoMarcia Angell makes it plain:The fact that drug companies pay prescribers to be "educated" underscores the true nature of the transaction. Students generally pay...
View ArticleSleepwalking party invitations and other delights
Sleepwalking party invitations and other delightsA roundup of wonderful stuff I won't get to. Then again, many of these need no help:"Come tomorrow and sort this hell hole out. Dinner and drinks, 4...
View ArticleSeroquel, preemption, prosecution, sex - Is the tide turning?
Seroquel, preemption, prosecution, sex - Is the tide turning?I'm having difficulty even reading, much less posting about, the river of stories about pharma and device industries, FDA regs, conflicts of...
View ArticleDerek Lowe (In The Pipeline) on ghostwriting and a real drug industry project...
Derek Lowe (In The Pipeline) on ghostwriting and a real drug industry project meetingI know that we have been very fortunate to attract a few new readers over the last year or so. For those, and as a...
View ArticleSell the drugs, they pay you. Criticize the drugs, they sue you.
Sell the drugs, they pay you. Criticize the drugs, they sue you. via Wall Street Journal Health Blog:For a while now, the FDA and other regulators have been looking at safety risks associated with a...
View ArticleThe Rise Of Marketing-Based Medicine (via Pharmalot)
The Rise Of Marketing-Based Medicine (via Pharmalot)The Rise Of Marketing-Based Medicine64 CommentsBy Ed Silverman // January 28th, 2010 // 7:57 amYou've heard of evidence-based medicine. Well, a new...
View ArticleBig Pharma needs more money! (Wait a minute....does not compute...)
Big Pharma needs more money! (Wait a minute....does not compute...)In the Feb 26 issue of Science, the Chief Patent Counsel for GlaxoSmithKline has written a "Policy Forum" article outlining the...
View ArticleLatisse!
Latisse!The existence of the drug Latisse is clearly a harbinger of the end of modern civilization, in more ways than one, but it is also intensely fascinating and creepy. When I first heard of it,...
View ArticleThe Speed of Money
The Speed of MoneyWow! Either it's an odd coincidence, or the Latisse marketers are highly vigilant monetizers, because in less than 24 hours after I posted yesterday's rambling little piece about the...
View Article